ARRS
Annual Meeting: Analysis of Breast Radiation Therapy and Breast Arterial
Calcifications on Screening MammographySan
Diego, CA | May 1, 2025—Findings from a Certificate of Merit Online Poster presented
during the
2025 ARRS Annual Meeting suggest that breast radiation therapy exposure does not impact the prevalence
of mammographic breast arterial calcification—therefore, not impacting its
utility as an imaging biomarker of cardiovascular disease risk.
“Our study is the
first retrospective analysis of the association between breast cancer radiation
therapy exposure and the presence of breast arterial calcification on screening
mammography,” noted presenter
Jessica Rubino, MD, from Dartmouth
Hitchcock Medical Center in Lebanon, NH.
Rubino et al. performed an electronic health
database query to identify women ages 40–75 years who had a screening mammogram
between January 1, 2011 and December 31, 2012. After a chart review to extract
data regarding breast cancer radiation therapy history, two breast imaging
radiologists then reviewed mammograms for the presence of breast arterial
calcification. The researchers used multivariate logistic regression to examine
the association between breast radiation therapy exposure and breast arterial
calcification, adjusting for age, BMI, smoking status, hypertension, type 2
diabetes, as well as use of statin and antihypertensive medication.
Of the 1,155
women included in this analysis, 222 (19.2%) had mammographic evidence of
breast arterial calcification, 122 (10.6%) had a history of radiation therapy
exposure, and 39 (32%) women with radiation therapy exposure had breast
arterial calcification on the index mammogram obtained at least 2 years after
completing radiation therapy.
Compared to women without radiotherapy, women
with a history of breast radiation therapy exposure had higher odds of breast
arterial calcification (OR: 2.18, 95% CI: 1.43–3.28; p = 0.0008). After
multivariable adjustment, however, this association became nonsignificant, with
the maximally adjusted model demonstrating an OR of 1.52 (0.95–2.40; p =
0.07).
North America’s first radiological
society, the American Roentgen Ray Society (ARRS) remains dedicated to the
advancement of medicine through the profession of medical imaging and its
allied sciences. An international forum for progress in radiology since the
discovery of the x-ray, ARRS maintains its mission of improving health through
a community committed to advancing knowledge and skills with the ARRS Annual Meeting,
two radiology journals—American
Journal of Roentgenology (AJR) and Roentgen Ray Review (R3)—InPractice magazine, ARRS
Symposia, free-access multimedia from our Global Partner Societies,
as well as awarding scholarships via The Roentgen Fund®.MEDIA
CONTACT:
Logan K. Young, PIO
44211 Slatestone Court
Leesburg, VA 20176
[email protected]